抗血管生成的在nsclc的应用

抗血管生成的在nsclc的应用

ID:3808392

大小:3.62 MB

页数:35页

时间:2017-11-24

抗血管生成的在nsclc的应用_第1页
抗血管生成的在nsclc的应用_第2页
抗血管生成的在nsclc的应用_第3页
抗血管生成的在nsclc的应用_第4页
抗血管生成的在nsclc的应用_第5页
资源描述:

《抗血管生成的在nsclc的应用》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库

1、Whatistheoptimalclinicalapplicationsofanti-angiogenic-basedNSCLCstrategiestohelpmorepatientsinthemaintenanceandsecond-linesetting?JohnHeymach,MD,PhDAssociateProfessorThoracic/HeadandNeckMedicalOncologyandCancerBiologyFourthAnnualSymposiumonPersonalizedTherapies

2、andBestClinicalPracticesforLungCancerLosAngeles,CASeptember17,2011DisclosuresAdvisoryboardsforGenentechandAstraZenecaResearchsupportfromAstraZenecaCase#156yowomanwith15pack-yearhistorypresentswithamalignantpleuraleffusion,mediatinaladenopathy,anda3-4smallCNSmet

3、astases.Shehasbeenhavingmildheadachesrecently.Cytologyrevealsadenocarcinoma,TTF1+EGFRmutatationtestingcouldnotbeperformedfromcellblockandadditionalbiopsyrefused.SheisinitiallytreatedwithstereotacticXRTforherCNSlesionsandcomesforsystemictherapy. Whichchemothera

4、pyregimenisnotsupportedbyrandomizedphaseIIIdata?Carbo/pacCarbo/pac/BVPem/cisPem/carbo/BVQuestion1Question#1SheisinitiallytreatedwithstereotacticXRTforherCNSlesionsandcomesforsystemictherapy.WhichchemotherapyregimenisnotsupportedbyrandomizedphaseIIIdata?Carbo/pa

5、cCarbo/pac/BVPem/cisPem/carbo/BVCase#1Sheisstartedontreatmentwithcarboplatin,paclitaxel,andBVx6cycles.Shehasapartialresponse,toleratestreatmentwell,andwantstobetreatedaggressively.WhichmaintenancetherapyispartofaregimenthathasbeenshowntoprolongOSinarandomizedph

6、aseIIIstudy?BVmonotherapyPemetrexedBV+PemBV+erlotinibAandBA,B,andDNomaintenancetherapyQuestion2Question#2WhichmaintenancetherapyispartofaregimenthathasbeenshowntoprolongOSinarandomizedphaseIIIstudy?BVmonotherapyPemetrexedBV+PemBV+erlotinibAandBA,B,andDNomainten

7、ancetherapy12mo.24mo.43.7%16.9%51.9%22.1%0.00.20.40.60.81.0ProbabilityPCPCBP=0.007061218243036MonthsMedians:10.2,12.5HR:0.77(0.65,0.93)PhaseIIITrialofBevacizumab inNon-SquamousNSCLC(ECOG4599)Sandleretal,NEJM2006OverallsurvivalDoesBVmaintenanceprovidebenefitinfi

8、rst-lineNSCLC?InECOG4599,60.1%completed6cyclesofCPBand48%receivedBVmaintenance.44%completed6cyclesofCPwithoutPD.Sandleretal,ProcWorldLungmeeting2011,posterP3.216BVmaintNomai

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。